Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Equity | $7,235.0K | $10.5M | $13.9M | $11.5M | ($2,823.0K) | $123.9M | $192.8M | $134.3M | $120.9M | $143.3M | $186.2M | $311.7M | $154.5M | $361.1M | $208.3M | $261.7M | $275.9M | $410.5M | $88.0M | ($331.9M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Insmed Incorporated's last 12-month Total Equity is $285.4M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Insmed Incorporated's Total Equity growth was N/A. The average annual Total Equity growth rates for Insmed Incorporated have been (18.7%) over the past three years, 1.7% over the past five years.